SabinCA, SchwenkA, JohnsonMAet al.Late diagnosis in the HAART era: Proposed common definitions and associations with mortality. AIDS, 2010; 24,5:723–727.
2.
RodgerA, LodwickR, SchechterMet al.Mortality in Patients with Well-controlled HIV and High CD4 Counts in the cART Arms of the SMART and ESPRIT Randomized Clinical Trials Compared to the General Population. Abstract 638, 19th Conference on Retroviruses and Opportunistic Infections, 2012.
3.
NashD, KatyalM, BrinkhofMWGet al.Long-term immunologic response to antiretroviral therapy in low income countries: A collaborative analysis of prospective studies. AIDS, 2008; 22:2291–2302.
4.
CohenMS, ChenYQ, McCauleyMet al.Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med, 2011; 365:493–505.
5.
BuchaczK, ArmonC, PalellaFJet al.CD4 cell counts at HIV diagnosis among HIV outpatient study participants, 2000–2009. AIDS Res Treat, 2012; 869841.
6.
BorghiV, GirardiE, BellelliSet al.Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr, 2008; 49,3:282–286.
7.
LanoyE, Mary-KrauseM, TattevinPet al.Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther, 2007; 12,1:89–96.
8.
SáMS, SampaioJ, HaguiharaTet al.Clinical and laboratory profile of HIV-positive patients at the moment of diagnosis in Bahia, Brazil. Braz J Infect Dis, 2007; 11,4:395–398.
